N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids
- PMID: 23976843
- PMCID: PMC3746786
- DOI: 10.2147/DDDT.S48324
N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids
Abstract
N-Palmitoylethanolamine (NAE 16:0) is an endogenous lipid signaling molecule that has limited water solubility, and its action is short-lived due to its rapid metabolism. This poses a problem for use in vivo as oral administration requires a high concentration for significant levels to reach target tissues, and injection of the compound in a dimethyl sulfoxide- or ethanol-based vehicle is usually not desirable during long-term treatment. A depot injection of NAE 16:0 was successfully emulsified in sterile corn oil (10 mg/kg) and administered in young DBA/2 mice in order to elevate baseline levels of NAE 16:0 in target tissues. NAE 16:0 levels were increased in various tissues, particularly in the retina, 24 and 48 hours following injections. Increases ranged between 22% and 215% (above basal levels) in blood serum, heart, brain, and retina and induced an entourage effect by increasing levels of other 18 carbon N-Acylethanolamines (NAEs), which ranged between 31% and 117% above baseline. These results indicate that NAE 16:0 can be used as a depot preparation, avoiding the use of inadequate vehicles, and can provide the basis for designing tissue-specific dosing regimens for therapies involving NAEs and related compounds.
Keywords: DBA/2 mice; cannabinoid receptor; gas chromatography; lipid extraction; mass spectrometry; vanilloid receptor.
Figures
Similar articles
-
N-acylethanolamines are metabolized by lipoxygenase and amidohydrolase in competing pathways during cottonseed imbibition.Plant Physiol. 2002 Sep;130(1):391-401. doi: 10.1104/pp.004689. Plant Physiol. 2002. PMID: 12226518 Free PMC article.
-
Incorporation of labelled N-acylethanolamine (NAE) into rat brain regions in vivo and adaptive properties of saturated NAE under x-ray irradiation.Ukr Biokhim Zh (1999). 2005;77(6):51-62. Ukr Biokhim Zh (1999). 2005. PMID: 19618742
-
Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists.J Biol Chem. 2005 Nov 18;280(46):38496-504. doi: 10.1074/jbc.M507429200. Epub 2005 Aug 4. J Biol Chem. 2005. PMID: 16081411
-
The Basal Pharmacology of Palmitoylethanolamide.Int J Mol Sci. 2020 Oct 26;21(21):7942. doi: 10.3390/ijms21217942. Int J Mol Sci. 2020. PMID: 33114698 Free PMC article. Review.
-
N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).Prog Lipid Res. 2010 Oct;49(4):299-315. doi: 10.1016/j.plipres.2010.02.003. Epub 2010 Feb 10. Prog Lipid Res. 2010. PMID: 20152858 Review.
Cited by
-
Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies.Neural Regen Res. 2024 Apr;19(4):788-799. doi: 10.4103/1673-5374.382220. Neural Regen Res. 2024. PMID: 37843213 Free PMC article. Review.
-
Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study.Int J Mol Sci. 2023 Mar 13;24(6):5503. doi: 10.3390/ijms24065503. Int J Mol Sci. 2023. PMID: 36982577 Free PMC article.
-
Novel Machine-Learning Based Framework Using Electroretinography Data for the Detection of Early-Stage Glaucoma.Front Neurosci. 2022 May 4;16:869137. doi: 10.3389/fnins.2022.869137. eCollection 2022. Front Neurosci. 2022. PMID: 35600610 Free PMC article.
-
The Contribution of Anterior Segment Abnormalities to Changes in Intraocular Pressure in the DBA/2J Mouse Model of Glaucoma: DBA/2J-Gpnmb +/SjJ Mice as Critical Controls.Front Neurosci. 2022 Feb 3;15:801184. doi: 10.3389/fnins.2021.801184. eCollection 2021. Front Neurosci. 2022. PMID: 35185449 Free PMC article.
-
Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice.Neurosci Insights. 2020 Nov 25;15:2633105520975412. doi: 10.1177/2633105520975412. eCollection 2020. Neurosci Insights. 2020. PMID: 33294845 Free PMC article.
References
-
- Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ. The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem. 2002;9(6):663–674. - PubMed
-
- Jian W, Edom R, Weng N, Zannikos P, Zhang Z, Wang H. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(20):1687–1699. - PubMed
-
- Day TA, Rakhshan F, Deutsch DG, Barker EL. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Mol Pharmacol. 2001;59(6):1369–1375. - PubMed
-
- Lombardi G, Miglio G, Varsaldi F, Minassi A, Appendino G. Oxyhomologation of the amide bond potentiates neuroprotective effects of the endolipid N-palmitoylethanolamine. J Pharmacol Exp Ther. 2007;320(2):599–606. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 AG022550/AG/NIA NIH HHS/United States
- P01 AG027956/AG/NIA NIH HHS/United States
- AG022550/AG/NIA NIH HHS/United States
- P01 AG010485/AG/NIA NIH HHS/United States
- EY022774/EY/NEI NIH HHS/United States
- RR022570/RR/NCRR NIH HHS/United States
- RR027093/RR/NCRR NIH HHS/United States
- AG010485/AG/NIA NIH HHS/United States
- R01 EY014227/EY/NEI NIH HHS/United States
- EY014227/EY/NEI NIH HHS/United States
- R01 EY022774/EY/NEI NIH HHS/United States
- AG027956/AG/NIA NIH HHS/United States
- S10 RR027093/RR/NCRR NIH HHS/United States
- S10 RR022570/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
